COVID-19
| 1 min read
First step is to assess potential therapeutics for COVID-19
| 3 min read
BNT162b2 immunization of rhesus macaques results in strong antiviral effects against SARS-CoV-2
| 3 min read
The FDA has authorized the first COVID-19 test for self-testing at home
| 2 min read
Precision NanoSystems is developing an mRNA vaccine candidate lipid nanoparticle with CanSinoBIO
| 3 min read
Medicago reports positive Phase 1 data for plant-derived COVID-19 vaccine, advances into Phase 2/3 trials
| 2 min read
The mRNA-based vaccine was more than 90-percent effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2
| 1 min read
While the race for a vaccine targeting the SARS-CoV-2 coronavirus is expected to take another year or so, there is an increasingly urgent need to fight the disease in those already infected.
